All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
Mon 2012-12-10? to Thu 2025-10-16 |
YTD
Return |
TRR
Price |
||||
---|---|---|---|---|---|---|
ABBV × |
+28.25%
2025-10-16 |
7.706 TRR
2025-10-16 |
||||
AbbVie Inc NYSE Common Stock | ||||||
Mon 2012-12-10? to Thu 2025-10-16 |
Overall
Return |
Exponential
Trendline |
||||
---|---|---|---|---|---|---|
ABBV × |
+670.62%
+17.23%/yr |
+14.35%/yr
(R2=0.945) |
||||
AbbVie Inc NYSE Common Stock | ||||||
Mon 2012-12-10? to Thu 2025-10-16 |
Start
Value |
End
Value |
||||
---|---|---|---|---|---|---|
ABBV × |
$10,000.00
2012-12-10 |
$77,061.82
2025-10-16 |
||||
AbbVie Inc NYSE Common Stock | ||||||
Year | ABBV |
---|---|
2025 (YTD) | +28.25% |
2024 | +15.54% |
2023 | −3.47% |
2022 | +16.47% |
2021 | +23.72% |
2020 | +26.00% |
2019 | −0.80% |
2018 | −2.81% |
2017 | +56.77% |
2016 | +7.56% |
2015 | −7.17% |
2014 | +26.96% |
2013 | +58.41% |
2012 | −2.24% |
Mon 2012-12-10? to Thu 2025-10-16 |
Current
Drawdown |
Worst
Drawdown |
||||
---|---|---|---|---|---|---|
ABBV × | −6.61% |
−46.99%
2019-08-15 |
||||
AbbVie Inc NYSE Common Stock | ||||||